Acute and maintenance treatment of bipolar mania: The role of atypical antipsychotics

Bipolar Disorders, Supplement

Volumn 5, Issue 2, 2003, Pages 7-19

  Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acute treatment; Atypical antipsychotics; Bipolar disorder; Maintenance; Mania; Remission

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; LITHIUM DERIVATIVE; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ACUTE DISEASE; AKATHISIA; ANXIETY DISORDER; APPETITE DISORDER; ASTHENIA; BIPOLAR MANIA; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; COMORBIDITY; DATA ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; DYSPEPSIA; EDEMA; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HUMAN; HYPERKINESIA; MAINTENANCE THERAPY; MANIA; MUSCLE HYPERTONIA; NAUSEA; ORTHOSTATIC HYPOTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; REVIEW; RHINITIS; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; SPEECH DISORDER; SUBSTANCE ABUSE; TREATMENT OUTCOME; WEIGHT GAIN; XEROSTOMIA;

EID: 1842451923     PISSN: 13992406     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-2406.2003.00060.x     Document Type: Review

References (52)

1. World Health Organization. World Health Report: Mental health: New Understanding, New Hope. Geneva: World Health Organization, 2001
2. Judd L, Akiskal H, Schettler P et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch General Psychiatry 2002; 59: 530-537.
3. Miller D, Yatham L, Lam R. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. J Clin Psychiatry 2001; 62: 975-980.
4. Sernyak M, Griffin R, Johnson R, Pearsall H, Wexler B, Woods S. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994; 151: 133-135.
5. Zarate C, Tohen M. Antipsychotic drug treatment in first-episode mania: A 6-month longitudinal study. J Clin Psychiatry 2000; 61: 33-38.
6. Chou J. Recent advances in treatment of acute mania. J Clin Psychopharmacol 1991; 11: 3-21.
7. Tohen M, Zarate C. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998; 59 (Suppl. 1): 38-48.
8. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980; 13: 156-167.
9. Littlejohn R, Leslie F, Cookson J. Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiatry 1994; 165: 827-829.
10. Esparon J, Kolloori J, Naylor G, McHarg A, Smith A, Hopwood S. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 1986; 148: 723-725.
11. Kane J. Tardive dyskinesia in affective disorders. J Clin Psychiatry 1999; 60 (Suppl. 5): 43-47.
12. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159: 1-50.
13. Hirschfeld R, Keck P, Karcher K, Kramer M, Grossman F, Vieta E. Rapid antimanic effect of risperidone monotherapy: A 3-week multicenter, double-blind, placebo-controlled trial [Abstract NR182]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
14. Vieta E, Khanna B, Grossman F, van Kammen D, Kramer M. Risperidone in the treatment of manic or mixed episodes of bipolar disorder [Abstract]. Presented at ACNP, Puerto Rico, 2002.
15. Gopal S, Kramer M, Olsen M, Steffens D. Mania remission rates in a randomized-controlled trial of risperidone [Abstract NR515]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
16. Tohen M, Sanger T, McElroy S et al. Olanzapine versus placebo in the treatment of acute mania. The Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-709.
17. Tohen M, Jacobs T, Grundy S et al. Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch General Psychiatry 2000; 57: 841-849.
18. Keck P, Versiani M, Potkin S, West S, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003; 160: 741-748.
19. Marcus R, Saha A, Jody D, Tourkodimitris S, Archibald D, Iwamoto T. Aripiprazole versus placebo in acute mania [Abstract P.2.081]. J Eur Coll Neuropsychopharmacol 2002; 12 (Suppl. 3): S289.
20. Eerdekens M, Karcher K, Grossman F, Kramer M. Risperidone monotherapy in acute bipolar mania. Presented at the World Psychiatric Association Meeting, Vienna, Austria, June 18-21, 2003.
21. Jones M, Huizar K. Quetiapine monotherapy for acute mania associated with bipolar disorder (STAMP 1 and STAMP 2) [Abstract NR432]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
22. Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial. Clin Neuropharmacol 1998; 21: 176-180.
23. Tohen M, Baker R, Altshuler L et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002; 159: 1011-1017.
24. Zajecka J, Weisler R, Sachs G, Swann A, Wozniak P, Sommerville K. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002; 63: 1148-1155.
25. Berk M, Ichim L, Brook S. Olanzapine compared with lithium in mania: A double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14: 339-343.
26. Shi L, Namjoshi M, Zhang F et al. Olanzapine versus haloperidol in the treatment of acute mania: Clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17: 227-237.
27. Tohen M, Goldberg J, Gonzales-Pinto A et al. A 12-week double blind comparison of olanzapine versus haloperidol in the treatment of acute mania. Arch General Psychiatry 2003 (in press).
28. Bourin M, Auby P, Marcus R et al. Aripiprazole versus haloperidol for maintained treatment effect in acute mania [Abstract NR467]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
29. Baker R, Zarate C, Jr Brown E, Schuh L, Tohen M. A three-week comparison of olanzapine versus risperidone in the treatment of bipolar mania: Improvement in manic and depressive symptoms and treatment adherence [Abstract 15]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
30. Sachs G, Grossman F, Ghaemi S, Okamoto A, Bowden C. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146-1154.
31. Yatham L, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial. Br J Psychiatry 2003; 182: 141-147.
32. Mullen J, Devine N, Sweitzer D. Quetiapine adjunctive therapy for acute mania associated with bipolar disorder (SIAM) [Abstract NR482]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
33. Delbello M, Schwiers M, Rosenberg H, Strakowski S. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002; 41: 1216-1223.
34. Tohen M, Chengappa K, Suppes T et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch General Psychiatry 2002; 59: 62-69.
35. Yatham L, Binder C, Kusumakar V, Riccardelli R. Risperidone added to mood stabilizers in mania; is there a difference in effect depending on mood stabilizer? [Abstract P.1.078]. J Eur Coll Neuropsychopharmacol 2002; 12 (Suppl. 3): S202.
36. Canuso C, Zhu Y, Bossie C, Grossman F. Remission with risperidone in combination With mood stabilizers in acute bipolar mania [Abstract NR503]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
37. Chengappa K, Baker R, Shao L et al. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord 2003; 5: 1-5.
38. Sanger T, Tohen M, Vieta E et al. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord 2003; 73: 155-161.
39. Baker R, Milton D, Stauffer V, Gelenberg A, Tohen M. Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. J Affect Disord 2003; 73: 147-153.
40. Shi L, Namjoshi M, Juarez R et al. Olanzapine versus haloperidol as initial treatment in acute mania: Prospective comparison of work functional outcomes [Abstract P.2.125]. J Eur Coll Neuropsychopharmacol 2002; 12 (Suppl. 3):S307.
41. Shi L, Wilson M, Namjoshi M, Baker R, Tohen M. Cognitive function associated with olanzapine in the treatment of acute mania: Is cognitive improvement a marker of clinical improvement in manic symptoms? [Abstract P 2 E 057]. Int J Neuropsychopharmacol 2002; 5 (Suppl. 1). Available at http://www.cinp2002.com/abstracts/.
42. Reinares M, Martinez-Aran A, Colom F, Benabarre A, Salamero M, Vieta E. Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients. Actas Esp Psiquiatr 2000; 28: 231-238.
43. Guille C, Sachs G, Ghaemi S. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2000; 61: 638-642.
44. Tohen M, Bowde C, Calabrese J et al. Olanzapine versus placebo for relapse prevention in bipolar disorder [Abstract NR197]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
45. Baker R, Tohen M, Brown E, Schuh L, Zarate C Jr, Suppes T. Olanzapine versus divalproex sodium for bipolar mania in rapid cyclers [Abstract P.2.005]. J Eur Coll Neuropsychopharmacol 2002; 12 (Suppl. 3): S256.
46. Yurgelun-Todd D, Shi L, Zhu B et al. Olanzapine vs divalproex: Prospective comparison on self-reported cognitive function in patients with bipolar disorder [Abstract P.2.128]. J Eur Coll Neuropsychopharmacol 2002; 12 (Suppl. 3): S308.
47. Tohen M, Marneros A, Bowden C et al. Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial [Abstract]. Bipolar Disord 2002; 4 (Suppl. 1).
48. Tohen M, Suppes T, Baker R, Risser R, Evans A, Calabrese J. Olanzapine combined with mood stabilizers in prevention of recurrence in bipolar disorder: An 18-month study [Abstract P.2.124]. J Eur Coll Neuropsychopharmacol 2002; 12 (Suppl. 3): S307.
49. Tohen M, Ketter T, Calabrese J et al. Long-term use of olanzapine or olanzapine/fluoxetine for bipolar depression [Abstract NR510]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
50. Yatham LN, Binder C, Ricardelli R, Connoly M, Leblane J, Kusumakar V. Risperidone in acute and continuation treatment of mania. Int Clin Psychopharmacol 2003; 18: 237-244.
51. Khanna S, Hirschfeld R, Karcher K, Grossman F, Kramer M. Risperidone monotherapy in acute bipolar mania [Abstract NR424]. Presented at 156th APA Annual Meeting, San Francisco, CA, May 17-22, 2003.
52. Vieta E, Goikolea J, Corbella B et al. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 2001; 62: 818-825.